Sulfopin

selective covalent Pin1 inhibitor

oral efficacy in xenograft model

from covalent fragment screen and opt.

bioRxiv, Mar. 21, 2020

Weizmann Institute / Harvard Medical

Sulfopin (Weizmann/Harvard selective covalent Pin1 inhibitor)


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks